QGEN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Qiagen NV (QGEN) is not a strong buy at the moment for a beginner investor with a long-term focus. While the company has shown positive financial performance in the latest quarter, the technical indicators suggest a bearish trend, and there are no strong positive catalysts or trading signals to justify immediate action. A hold strategy is recommended until better entry points or clearer positive signals emerge.
The MACD is negative and expanding, indicating bearish momentum. RSI is at 24.077, suggesting the stock is nearing oversold territory but not yet a clear buy signal. Moving averages are converging, showing no strong trend direction. The stock is trading below key support levels (S1: 46.725, S2: 45.876), further reinforcing the bearish sentiment.
The company delivered strong Q4 financials with revenue up 3.69% YoY, net income up 22.09% YoY, and EPS up 28.95% YoY. Analysts have raised price targets, with some maintaining overweight ratings, signaling potential long-term growth.
Hedge funds are selling heavily, with a 286.76% increase in selling activity last quarter. Gross margin dropped by -6.94% YoY, indicating potential cost pressures. No recent news or congress trading activity to act as a catalyst. The stock has a high chance of declining further in the short term (-1.85% in the next week, -3.31% in the next month).
In Q4 2025, Qiagen reported revenue of $540.42M (up 3.69% YoY), net income of $107.83M (up 22.09% YoY), and EPS of $0.49 (up 28.95% YoY). However, gross margin dropped to 59.77% (down -6.94% YoY), which may indicate rising costs or pricing pressures.
Analysts have raised price targets, with the highest being $60 (JPMorgan) and the lowest at EUR 43 (Morgan Stanley). Ratings are mixed, with some maintaining overweight or buy ratings, while others are neutral or hold. Deutsche Bank downgraded the stock to Hold, citing takeover speculation and fair valuation concerns.
